Shigeru Morikawa - Infectious Diseases

Author Information

Shigeru Morikawa is affiliated with the Department of Veterinary Science at the National Institute of Infectious Diseases in Tokyo, Japan. His work primarily focuses on infectious diseases, contributing significantly to our understanding of various viral infections and their impacts on both human and animal health.

Research Contributions

Shigeru Morikawa has made substantial contributions to the field of infectious diseases, with a particular emphasis on viral pathogens. His research encompasses a wide range of topics including the study of severe fever with thrombocytopenia syndrome (SFTS), Crimean-Congo hemorrhagic fever, and the immunological responses to SARS-CoV-2 in animals. His work not only enhances the understanding of the pathology and transmission of these diseases but also contributes to the development of diagnostic tools and therapeutic strategies.

Aliases

Shigeru Morikawa is also known by several aliases including S Morikawa, S. Morikawa, and Sh. Morikawa. These variations are used across different publications and academic contributions.

Publication and Citation Metrics

Metric	Value
Number of Papers	436
Citation Count	11,568
H-Index	58

Publications:

Possible Cause of Liver Failure in Patient with Dengue Shock Syndrome

DOI:

Year: 2022

Reverse Genetics System for Heartland Bandavirus: NSs Protein Contributes to Heartland Bandavirus Virulence

DOI: 10.1128/jvi.00049-22

Year: 2022

Serological Study of SARS-CoV-2 Antibodies in Japanese Cats: Analysis of Risk Factors Among Cat Lifestyles

DOI: 10.21203/rs.3.rs-1113354/v1

Year: 2022

Epitope Mapping of A Viral Propagation-Inhibiting Single-Chain Variable Fragment Against Rabies Lyssavirus Phosphoprotein.

DOI: 10.1089/mab.2021.0020

Year: 2022

Pathological Characteristics of Severe Fever With Thrombocytopenia Syndrome (SFTS) Virus in a Patient Infected With Sfts Virus From a Sick Cat’s Bite

DOI: 10.20944/PREPRINTS202101.0207.V1

Year: 2021

Seroepidemiological study of severe fever with thrombocytopenia syndrome in animals and humans in Okinawa, Japan.

DOI: 10.1016/j.ttbdis.2021.101821

Year: 2021

Serologic and molecular evidence for circulation of Crimean-Congo hemorrhagic fever virus in ticks and cattle in Zambia

DOI: 10.1371/journal.pntd.0009452

Year: 2021

Pathological Characteristics of a Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected with SFTS Virus through a Sick Cat’s Bite

DOI: 10.3390/v13020204

Year: 2021

Diagnostic system for the detection of severe fever with thrombocytopenia syndrome virus RNA from suspected infected animals

DOI: 10.1371/journal.pone.0238671

Year: 2021

Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis

DOI: 10.1038/s41598-021-81752-0

Year: 2021

What is Protein Targeting?

What is Safety in the Context of Infectious Diseases?

What is Pathogenesis?

How Does PCR Work?

What are Some Disorders Involving B Cells?

What are the Symptoms of Strep Throat?

How Is Muscle and Joint Pain Diagnosed in the Context of Infectious Diseases?

What are the Risk Factors for E. Coli Infection?

What are the Symptoms of Schistosomiasis?

How Do CRISPR-Cas Systems Work?

Partnered Content Networks

Relevant Topics